Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002043170-24-000001
Filing Date
2024-11-01
Accepted
2024-11-01 15:46:30
Documents
1
Effectiveness Date
2024-11-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10562
  Complete submission text file 0002043170-24-000001.txt   11620
Mailing Address 75 KNEELAND STREET, 14 FL BOSTON MA 02111
Business Address 75 KNEELAND STREET, 14 FL BOSTON MA 02111 617-299-8479
Axonis Therapeutics, Inc. (Filer) CIK: 0002043170 (see all company filings)

EIN.: 272454388 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-528494 | Film No.: 241418909